Stem cells: General aspects, biological and molecular events;Células madre: Generalidades, eventos biológicos y moleculares

Iatreia

Volumn 21, Issue 3, 2008, Pages 292-306

  Acevedo Toro, Paola Andrea ^a   Cortés Márquez, Mónica María ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

Author keywords

ARF 1 protein; BMI 1 gene; Differentiation; Microenviroment; NANOG gene; Notch receptors; OCT3 4 genes; p16Ink4a genes; Self renewal; SOX2 gene; Stem cells; Transcription factors; Wnt proteins

Indexed keywords

ARF PROTEIN; BMI1 PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; HOMEODOMAIN PROTEIN; NOTCH RECEPTOR; OCTAMER TRANSCRIPTION FACTOR 4; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR HOXB4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG; WNT PROTEIN;

CELL DIFFERENTIATION; CELL PROLIFERATION; CELL RENEWAL; CELL TYPE; CHROMOSOME REARRANGEMENT; GENE FUNCTION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; STEM CELL;

EID: 54249147470     PISSN: 01210793     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (88)

1. Maximow AA. Relation of blood cells to connective tissues and endothelium. Physiol Rev 1924; 4: 533-563.
2. Jesper B, David AH, Jan AN. Recent advances in hematopoietic stem cell biology. Curr Opin Hematol 2004; 11: 392-398.
3. Piscaglia AC, Zocco MA, Di Campli C, Sparano L, Rutella S, Monego G, et al. How does human stem cell therapy influence gene expression after liver injury. Microarray evaluation on a rat model. Dig Liver Dis 2005; 37: 952-963.
4. Preston SL, Alison M, Forbes S, Direkze C, Poulsom R, Wright N. The new stem cell biology: something for everyone. J Clin Pathol Mol Pathol 2003; 96: 56-86.
5. Rodríguez V. Células madre: conceptos generales y perspectivas de investigación. Universitas Scientiarum 2005; 10: 5-14.
6. Giraldo J, Madero J, Ávila M, Cuneo S, López C, Escobar M, et al. Células madre. Rev Col Obstetr Ginecol 2003; 54: 87-96.
7. Sanchez JM. Terapia celular en enfermedades cardiovasculares y renales. Iatreia 2006; 19: 164-171.
8. Rodríguez VM, Cuéllar A, Cuspoca LM, Contreras CL, Mercado M, Gomez A. Determinación fenotípica de subpoblaciones de células madre derivadas de sangre de cordón umbilical. Biomédica 2006; 26: 51-60.
9. Holyoake TL, Nicolini FE, Eaves CJ. Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrow. Exp Hematol 1999; 27: 1418-1427.
10. Lapidos K, Chen Y, Earley J, Heydemann A, Huber J, Chien M, et al. Transplanted hematopoietic stem cells demonstrate impaired sarcoglycan expression after engraftment into cardiac and sbeletal muscle. J Clin Invest 2004; 114: 1577-1585.
11. Jiang Y, Vaessen B, Lenvik T, Blackstad M, Reyes M, Verfaillie CM. Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp Hematol 2002; 30: 896-904.
12. Prosper F, Verfaillie CM. Células madre adultas. An Sist Sanit Navar 2003; 26: 345-356.
13. a ed. Totowa, NJ: Humana Press; 2002; pp. 161-180.
14. a ed. Madrid: Harcourt; 2001; pp. 1-33.
15. a ed. Philadelphia: Elsevier Churchill Livingstone: 2005.
16. Rattis F, Voermans C, Reya T. Wnt signaling in the stem cell niche. Curr Opin Hematol 2004; 11: 88-94.
17. Ronzoni L, Bonara P, Rusconi D, Frugoni C, Libani I, Domenica C. Erythroid differentiation and maturation from peripheral CD34+ cells in liquid culture: Cellular and molecular characterization. Blood Cells Mol Dis 2008; 40: 148-155.
18. Bray SJ. Notch signaling: a simple pathway becomes complex. Nat Rev Mol Cell Biol 2006; 7: 678-689.
19. Qu K, Ortoleva P. Understanding stem cell differentiation through self-organization theory. J Theor Biol 2007; 250: 606-620.
20. Roeder I, Glauche I. Towards an understanding of lineage specification in hematopoietic stem cells: a mathematical model for the interaction of transcription factors GATA-1 and PU. 1. J Theor Biol 2006; 241: 852-865.
21. Laricchia-Robbio L, Nucifora G. Significant increase of self-renewal in hematopoietic cells after forced expression of EVI1. Blood Cells Mol Dis 2008; 40: 141-147.
22. Jordan CT, Guzman ML, Noble M. Cancer stem cells. N Engl J Med 2006; 12: 1253-1261.
23. Walkley CR, Fero ML, Chien WM, Purton LE, McArthur GA. Negative cell cycle regulators cooperatively regulate self-renewal and differentiation of haematopoietic stem cells. Nat Cell Biol 2005; 7: 172-178.
24. Yu H, Yuan Y, Shen H, Cheng T. Hematopoietic stem cell exhaustion impacted by p18 INK4C and p21 Cip1/Waf1 in opposite manners. Blood 2006; 107: 1200-1206.
25. Van Den Berg D, Sharma AK, Bruno E, Hoffman R. Role of members of the Wnt gene family in human hematopoyesis. Blood 1998; 92: 3189-3202.
26. Nusse R. Wnts and Hedgehogs: lipid-modified proteins and similarities in signaling mechanisms at the cell surface. Development 2003; 130: 5297-5305.
27. Staal FJT, Clevers HC. WNT signalling and haematopoiesis: a WNT-WNT situation. Nat Rev Immunol 2005; 5: 21-30.
28. Taipale J, Beachy P. The Hedgehog and Wnt signalling pathways in cancer. Nature 2001; 411: 349-354.
29. Willert K, Brown JD, Danenberg E, Duncan AW, Weissman IL, Reya T, et al. Wnt proteins are lipidmodified and can act as stem cell growth factors. Nature 2003; 423: 448-452.
30. Takemaru K, Yamaguchi S, Lee YS, Zhang Y, Carthew RW, Moon RT. Chibby, a nuclear B-catenin associated antagonist of the Wnt/Wingless pathway. Nature 2003; 422: 905-909.
31. Reya T, Duncan AW, Ailles L, Domen J, Scherer DC, Willert K, et al. A role for Wnt signaling in self-renewal of haematopoietic stem cells. Nature 2003; 423: 409-414.
32. Jia L, Zhou S, Peng S, Li J, Cao Y, Duan E. Effects of Wnt3a on proliferation and differentiation of human epidermal stem cells. Biochem Biophys Res Commun 2008; 368: 483-488.
33. Owens D, Watt F. Contribution of stem cells and differentiated cells to epidermal tumours. Nat Rev Cancer 2003; 3: 444-451.
34. Dravid A, Ye H, Hammond G, Chen AP, Donovan P, Cheng Y. Defining the role of Wnt/b-catenin signaling in the survival, proliferation and self-renewal of human embryonic stem cells. Stem Cells 2005; 23: 1489-1501.
35. Mumm JS, Kopan R. Notch signaling: from the outside in. Dev Biol 2000; 228: 151-165.
36. Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science 1999; 284: 770-776.
37. Milner LA, Bigas A. Notch as a mediator of cell fate determination in hematopiesis: evidence and speculation. Blood 1999; 93: 2431-2448.
38. Aster JC, Pear WS. Notch signaling in leukemia. Curr Opin Hematol 2001; 8: 237-244.
39. Bigas A, Martin DI, Milner LA. Notch1 and Notch2 inhibit myeloid differentiation in response to different cytokines. Mol Cell Biol 1998; 18: 2324-2333.
40. Liu S, Dontu G, Wicha M. Mammary stem cells, self-renewal pathways, and carcinogenesis. Breast Cancer Res 2005; 7: 86-95.
41. Duncan AW, Rattis FM, DiMascio LN, Congdon KL, Pazianos G, Zhao C, et al. Integration of Notch and Wnt signaling in hematopoietic stem cell maintenance. Nat Immunol 2005; 6: 314-322.
42. Brennan K, Gardner P. Notching up another pathway. Bioassays 2002; 24: 405-410.
43. Iso T, Kedes L, Hamamori Y. HES and HERP families: Multiple effectors of the Notch signaling pathway. J Cell Physiol 2003; 194: 237-255.
44. Wu L, Aster JC, Blacklow SC, Lake R, Artavanis-Tsakonas S, Griffin JD. MAML1, a human homologue of Drosophila mastermind, is a transcriptional co-activator for NOTCH receptors. Nat Genet 2000; 26: 484-489.
45. Kalderon D. Transducing the Hedgehog signal. Cell 2000; 103: 371-374.
46. Hahn H, Christiansen J, Wicking C, Zaphiropoulos PG, Chidambaram A, Gerrard B, et al. A mammalian patched homolog is expressed in target tissues of sonic hedgehog and maps to a region associated with developmental abnormalities. J Biol Chem 1996; 271: 12125-12128.
47. Ingham PW. Transducing hedgehog: the story so far. EMBO J 1998; 17: 3505-3511.
48. Bhardwaj G, Murdoch B, Wu D, Baker DP, Williams KP, Chadwick K, et al. Sonic hedgehog induces the proliferation of primitive human hematopoietic cells via BMP regulation. Nat Immunol 2001; 2: 172-180.
49. Dahmane N, Ruiz A. Sonic hedgehog regulates the growth and patterning of the cerebellum. Development 1999; 126: 3089-3100.
50. Palma V, Lim DA, Dahmane N, Sanchez P, Brionne TC, Herzberg C D, et al. Sonic hedgehog controls stem cell behavior in the postnatal and adult brain. Development 2005; 132: 335-344.
51. Chen JK, Taipale J, Cooper MK, Beachy PA. Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened. Genes Dev 2002;16: 2743-2748.
52. Romer JT, Kimura H, Magdaleno S, Sasai K, Fuller C, Baines H, et al. Suppression of the Shh pathway using a small molecule inhibitor eliminates medulloblastoma in Ptc1 +/- p53-/- mice. Cancer Cell 2004; 6: 229-240.
53. Kubo M, Nakamura M, Tasaki A, Yamanaka N, Nakashima H, Nomura M, et al. Hedgehog signaling pathway is a new therapeutic target for patients with breast cancer. Cancer Res 2004; 64: 6071-6074.
54. Lewis MT. Hedgehog signaling in mouse mammary gland development and neoplasia. J Mammary Gland Biol Neoplasia 2001; 6: 53-66.
55. Lewis MT, Veltmaat JM. Next stop, the twilight zone: hedgehog network regulation of mammary gland development. J Mammary Gland Biol Neoplasia 2004; 9: 165-181.
56. Pasca di Magliano M, Hebrok M. Hedgehog signalling in cancer formation and maintenance. Nat Rev Cancer 2003; 3: 903-911.
57. Olsen CL, Hsu PP, Glienke J, Rubanyi GM, Brooks AR. Hedgehog- interacting protein is highly expressed in endothelial cells but down-regulated during angiogenesis and in several human tumors. BMC Cancer 2004; 4: 43-54.
58. Xie J, Johnson RL, Zhang X, Bare JW, Waldman FM, Cogen PH, et al. Mutations of the PATCHED gene in several types of sporadic extracutaneous tumors. Cancer Res 1997; 57: 2369-2372.
59. Kiyono T, Foster SA, Koop JI, McDougall JK, Galloway DA, Klingelhutz AJ. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 1998; 396: 84-88.
60. Grinstein P W. Cellular signaling in normal and cancerous stem cells. Cell Signal 2007; 19: 2428-2433.
61. Raaphorst FM. Self-renewal of hematopoietic and leukemic stem cells: a central role for the Polycomb-group gene Bmi-1. Trends Immunol 2003; 24: 522-524.
62. Park IK, Qian D, Kiel M, Becker MW, Pihalja M, Weissman IL, et al. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 2003; 423: 302-305.
63. Lessard J, Sauvageau G. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 2003; 423: 255-260.
64. Van der Lugt NM, Domen J, Linders K, Van Roon M, Robanus Maandag E, Riele TH, et al. Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene. Genes Dev 1994; 8: 757-769.
65. McGinnis W, Krumlauf R. Homeobox genes and axial patterning. Cell 1992; 68: 283-302.
66. Levine M, Hoey T. Homeobox proteins as sequence-specific transcription factors. Cell 1988; 55: 537-540.
67. Sauvageau G, Thornsteinsdottir U, Eaves CJ, Lawrence HJ, Largman C, Landsdorp PM, et al. Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo. Genes Dev 1995; 9: 1753-1765.
68. Thorsteinsdottir U, Sauvageau G, Humphries RK. Enhanced in vivo regenerative potential of HOXB4-transduced hematopoietic stem cells with regulation of their pool size. Blood 1999; 94: 2605-2612.
69. Brun AC, Bjornsson JM, Magnusson M, Larsson N, Leveen P, Ehinger M, et al. Hoxb4-deficient mice undergo normal hematopoietic development but exhibit a mild proliferation defect in hematopoietic stem cells. Blood 2004; 103: 4126-4133.
70. - cells induces an in vitro expansion of clonogenic and early progenitors. Exp Hematol 2000; 28: 569-574.
71. Zhu J, Giannola DM, Zhang Y, Rivera AJ, Emerson SG. NF-Y cooperates with USF 1/2 to induce the hematopoietic expression of HOXB4. Blood 2003; 102: 2420-2427.
72. Mitsui K, Tokuzawa Y, Itoh H, Segawa K, Murakami M, Takahashi K, et al. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 2003; 113: 631-642.
73. Palmieri SL, Peter W, Hess H, Scholer HR. Oct-4 transcription factor is differentially expressed in the mouse embryo during establishment of the first two extraembryonic cell lineages involved in implantation. Dev Biol 1994; 166: 259-267.
74. Bhattacharya B, Miura T, Brandenberger R, Mejido J, Luo Y, Yang AX, et al. Gene expression in human embryonic stem cell lines: unique molecular-signature. Blood 2004; 103: 2956-2964.
75. Ambrosetti DC, Scholer HR, Dailey L, Basilico C. Modulation of the activity of multiple transcriptional activation domains by the DNA binding domains mediates the synergistic action of Sox2 and Oct-3 on the fibroblast growth factor-4 enhancer. J Biol Chem 2000; 275: 23387-23397.
76. Yuan H, Corbi N, Basilico C, Dailey L. Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3. Genes Dev 1995; 9: 2635-2645.
77. Nishimoto M, Fukushima A, Okuda A, Muramatsu M. The gene for the embryonic stem cell coactivator UTF1 carries a regulatory element which selectively interacts with a complex composed of Oct-3/4 and Sox-2. Mol Cell Biol 1999; 19: 5453-5465.
78. Kuroda T, Tada M, Kubota H, Kimura H, Hatano SY, Suemori H, et al. Octamer and Sox elements are required for transcriptional cis regulation of Nanog gene expression. Mol Cell Biol 2005; 25: 2475-2485.
79. Rodda DJ, Chew JL, Lim LH, Loh YH, Wang B, Ng HH, et al. Transcriptional regulation of nanog by OCT4 and SOX2. J Biol Chem 2005; 280: 24731-24737.
80. Pesce M, Scholer HR. Oct-4: gatekeeper in the beginnings of mammalian development. Stem Cells 2001; 19: 271-278.
81. Pan GJ, Chang ZY, Scholer HR, Pei D. Stem cell pluripotency and transcription factor Oct4. Cell Res 2002; 12: 321-329.
82. Niwa H. Molecular mechanism to maintain stem cell renewal of ES cells. Cell Struct Funct 2001; 26: 137-148.
83. Avilion AA, Nicolis SK, Pevny LH, Perez L, Vivian N, Lovell-Badge R. Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev 2003; 17: 126-140.
84. Hochedlinger K, Yamada Y, Beard C, Jaenisch R. Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell 2005; 121: 465-477.
85. Baron MH. Embryonic origins of mammalian hematopoiesis. Exp Hematol 2003; 31: 1160-1169.
86. Akashi K, Traver D, Miyamoto T, Weissman IL. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 2000; 404: 193-197.
87. Blank U, Karlsson G, Karlsson S. Signaling pathways governing stem-cell fat. Blood 2008; 111: 492-503.
88. Galan I, DeLeon JA, Diaz L, Hong JS, Muñoz MA, et al. Effect of a bone marrow microenvironment on the ex-vivo expansion of umbilical cord blood progenitor cells. Int J Lab Hematol 2007; 29: 58-63.